Skip to main content

Vor Biopharma Inc.

VOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001817229

No open-market purchases or sales by Vor Biopharma Inc. insiders were filed in the last 90 days; 155 institutions reported holding it in 13F filings for Q3 2026, worth $1.06B in total; no superinvestor holds it.

Key figures

Market capClose on Nov 20, 2026
$1.18B
Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ3 2026, +55 vs. previous quarter
155
13F valueReported value at the end of Q3 2026
$1.06B
Superinvestors holdingAt the end of Q3 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
–
No comparable prior period
Net income, FY2025
-$696.0M
No comparable prior period
Free cash flow, FY2025
-$143.7M
No comparable prior period
Revenue, Q3 FY2026
–
No comparable prior period

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
7.50M
Shares sold short
Change
+58.9K
+0.8% vs. previous
Days to cover
9.88
At average daily volume

Superinvestors holding VOR, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding VOR at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Vor Biopharma Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 21, 2026 (view filing)4:54 PM ETJul 165 daysLateRA Capital Healthcare Fund LP and 3 others10% OwnerSSale−213$19.75−$4.21K0.0%4.50M after
Apr 24, 2026 (view filing)6:12 PM ETApr 222 daysRA Capital Healthcare Fund LP and 3 othersDirector, 10% OwnerSSale−165.2K$15.77−$2.60M−6.4%2.40M after
Apr 21, 2026 (view filing)7:04 PM ETApr 17-204 daysRA Capital Healthcare Fund LP and 3 othersDirector, 10% OwnerSSale−630.4K$16.14−$10.2M−19.7%2.57M after2 lots
Apr 15, 2026 (view filing)5:29 PM ETApr 13-152 daysRA Capital Healthcare Fund LP and 3 othersDirector, 10% OwnerSSale−738.0K$16.10−$11.9M−18.8%3.20M after3 lots
Apr 10, 2026 (view filing)6:23 PM ETApr 8-102 daysRA Capital Healthcare Fund LP and 3 othersDirector, 10% OwnerSSale−620.1K$16.50−$10.2M−13.6%3.94M after4 lots
Apr 6, 2026 (view filing)6:51 PM ETApr 2-64 daysRA Capital Healthcare Fund LP and 3 othersDirector, 10% OwnerSSale−849.3K$17.10−$14.5M−15.7%4.56M after5 lots
Oct 30, 2025 (view filing)6:40 PM ETOct 28-302 daysRA Capital Healthcare Fund LP and 3 othersDirector, 10% OwnerSSale−400.4K$25.90−$10.4M−33.9%779.7K after4 lots
Oct 27, 2025 (view filing)8:04 PM ETOct 23-274 daysRA Capital Healthcare Fund LP and 3 othersDirector, 10% OwnerSSale−221.2K$28.06−$6.20M−15.8%1.18M after3 lots
Oct 22, 2025 (view filing)7:48 PM ETOct 20-212 daysRA Capital Healthcare Fund LP and 4 othersDirector, 10% OwnerSSale−117.0K$29.34−$3.43M−7.7%1.40M after5 lots
Oct 21, 2025 (view filing)5:45 PM ETOct 17-214 daysHoffman Reid and 1 other10% OwnerSSale−37.5K$30.19−$1.13M−3.1%1.17M after4 lots

Top 10 13F holders, Q3 2026

See all 155 holders

The largest institutional positions in Vor Biopharma Inc. at the end of Q3 2026; share changes are against Q2 2026.

Institutions holding VOR in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC6,759,007$129.0M0.01%+1,826,858+37.0%Added
TCG Crossover Management, LLC5,673,078$108.2M3.06%00.0%Unchanged
Ra Capital Management, L.P.4,503,882$85.9M0.86%+2,101,787+87.5%Added
FCPM III Services B.V.3,405,279$65.0M6.13%−712,075−17.3%Reduced
BlackRock, Inc.3,306,494$63.1M0.00%−161,613−4.7%Reduced
VR Adviser, LLC3,041,719$58.0M2.82%00.0%Unchanged
Frazier Life Sciences Management, L.P.2,743,939$52.4M1.30%+200,000+7.9%Added
Vanguard Capital Management LLC2,035,477$38.8M0.00%−48,851−2.3%Reduced
State Street Corp1,969,801$37.6M0.00%−646,535−24.7%Reduced
Caligan Partners LP1,925,066$36.7M2.25%00.0%Unchanged

Holders of 5% or more of VOR

See all 8 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Vor Biopharma Inc..

Largest holders of VOR from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Ra Capital Management, L.P.13D/A19.90%12.9M shares0.00 ppfrom 19.90%Feb 19, 202119 filingsJul 21, 2026SEC
Reprogrammed Interchange LLC13D/A17.60%1.20M shares−1.00 ppfrom 18.60%Jan 7, 20259 filingsOct 17, 2025SEC
FMR LLC13G/A10.70%6.32M shares−1.30 ppfrom 12.00%Nov 7, 20256 filingsNov 5, 2026SEC
ForGrowth III PA B.V.13D9.99%10.2M shares0.00 ppfrom 9.99%Sep 23, 20252 filingsDec 23, 2025SEC
Venrock Healthcare Capital Partners III, L.P.13G/A9.90%6.44M shares0.00 ppfrom 9.90%Sep 25, 20255 filingsNov 16, 2026SEC